Results 81 to 90 of about 14,273 (209)

Role of endothelin-1 in lung disease [PDF]

open access: yes, 2001
Endothelin-1 (ET-1) is a 21 amino acid peptide with diverse biological activity that has been implicated in numerous diseases. ET-1 is a potent mitogen regulator of smooth muscle tone, and inflammatory mediator that may play a key role in diseases of the
Rodman David M   +2 more
core   +2 more sources

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu   +3 more
wiley   +1 more source

Anomalies of Pulmonary Circulation as a Cause of Hemoptysis: A Series of Unusual Cases and Review of the Literature

open access: yesOman Medical Journal, 2015
The expectoration of blood originating from the lower respiratory tract, called hemoptysis, is a common clinical condition with many potential etiologies. Massive hemoptysis is life threatening and needs urgent intervention.
Kamini Gupta   +3 more
doaj   +1 more source

Tensin1 expression and function in chronic obstructive pulmonary disease [PDF]

open access: yes, 2019
open access articleChronic obstructive pulmonary disease (COPD) constitutes a major cause of morbidity and mortality. Genome wide association studies have shown significant associations between airflow obstruction or COPD with a non-synonymous SNP in ...
Amrani, Y.   +7 more
core   +1 more source

Biomarkers of lung congestion and injury in acute heart failure

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi   +9 more
wiley   +1 more source

Anterior spinal artery syndrome after the embolisation of bronchial arteries to control hemoptysis: A warning

open access: yesSouth African Journal of Radiology, 1997
Spinal cord ischaemia following embolisation of bronchial arteries to control hemoptysis is reported.  This rare complication occurred despite lack of visualisation of blood supply to the spinal cord during preliminary arteriography.
P. Szkup, M. Hopley, A. Mochan
doaj   +1 more source

An unusual presentation of anomalous left coronary artery from the pulmonary artery (ALCAPA) syndrome in a 70-year-old man: a case report [PDF]

open access: yes, 2018
Background: We present a rare case of anomalous origin of the left coronary artery from the pulmonary artery syndrome in an elderly man, and we describe coronary computed tomographic angiographic imaging findings to improve diagnostic confidence for ...
Benea, Giorgio   +8 more
core   +1 more source

Features of Extracranial Hemodynamics in Children with Bronchial Asthma

open access: yesZdorovʹe Rebenka, 2014
The paper analyzes the performance of extracranial hemodynamics — volumetric and linear blood flow velocity, the state of peripheral vascular resistance and vascular reactivity at ultrasound Doppler examination of the internal carotid and vertebral ...
S.M. Nedelska, O.Yu Akulova
doaj   +1 more source

A rare and fatal respiratory disease: bronchial Dieulafoy’s disease

open access: yesTherapeutic Advances in Respiratory Disease, 2020
A 66-year-old woman had two severe episodes of massive hemoptysis without any premonitory symptoms, with approximately 400–500 ml blood each time. Bronchoscopic exam revealed a smooth and pulsatile protrusion that was approximately 8–10 mm in diameter ...
Shi-xia Liao   +5 more
doaj   +1 more source

Standardized Management Pathway to Prevent Acute Rejection After Liver Transplantation Following ICI Therapy for Downstaging HCC

open access: yesHealth Care Science, EarlyView.
Findings indicate that within a standardized clinical pathway integrating structured immunosuppression, therapeutic drug monitoring, and early complication surveillance, liver transplantation after ICI exposure can be performed safely without increased rejection risk.
Ning Wang   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy